---
title: "Aidea Pharma plans to launch a stock option incentive plan for 11.375 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246423239.md"
description: "According to the Zhitong Finance APP, Aidea Pharma disclosed its 2025 stock option incentive plan (draft), proposing to grant a total of 11.375 million stock options, accounting for approximately 2.703% of the company's total equity at the time of the announcement of the incentive plan draft. Among them, 9.1 million options will be granted initially, with a total of 45 individuals as the initial grantees, and the exercise price is set at 13.01 yuan per option"
datetime: "2025-06-27T12:15:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246423239.md)
  - [en](https://longbridge.com/en/news/246423239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246423239.md)
---

# Aidea Pharma plans to launch a stock option incentive plan for 11.375 million shares

According to the Zhitong Finance APP, Aidea Pharma (688488.SH) disclosed the draft of the 2025 stock option incentive plan, proposing to grant a total of 11.375 million stock options, accounting for approximately 2.703% of the company's total share capital at the time of the announcement of the incentive plan draft. Among them, 9.1 million options will be granted initially, with a total of 45 individuals as the initial grantees, and the exercise price is set at 13.01 yuan per option

### Related Stocks

- [688488.CN](https://longbridge.com/en/quote/688488.CN.md)

## Related News & Research

- [Bessent says Trump fixed Biden’s economy and it’s rising](https://longbridge.com/en/news/295985431.md)
- [Mark Sanders Highlights Growing Institutional Interest in Music Rights Through Asset-Based Investment Approach](https://longbridge.com/en/news/295679768.md)
- [FDA Issues Warning About Certain Products Containing Toxic Yellow Oleander](https://longbridge.com/en/news/295690341.md)
- [11:44 ETAurisco Pharmaceutical est le premier fabricant mondial d'oligonucléotides génériques à avoir passé avec succès l'inspection de l'USFDA](https://longbridge.com/en/news/295954532.md)
- [Can GLP-1s affect birth control, fertility?](https://longbridge.com/en/news/295570271.md)